Louria Hayon Igal 4
4 · Raphael Pharmaceutical Inc. · Filed Mar 13, 2023
Insider Transaction Report
Form 4
Louria Hayon Igal
DirectorChief Technology Officer
Transactions
- Award
Warrants to Purchase Common Stock
2022-12-05+999,000→ 990,000 totalExercise: $0.01Exp: 2024-07-05→ Common Stock (990,000 underlying)
Footnotes (1)
- [F1]The warrants are exercisable immediately.